Search

shutterstock_2261453831(1) (1)

Announcements

Announcements

HOMEWhat’s NewAnnouncements

2025.May.12

The BOD resolved to rename the Remuneration Committee to the Remuneration and Nomination Committee

2025.May.12

Announcement of the Consolidated Financial Statements for the first quarter of 2025 were approved by the Board of Directors

2025.May.12

Announcement on behalf of Amaran that its institutional director changes its representative

2025.May.12

Announcement on behalf of Amaran of the resignation of its representative of institutional director

2025.May.12

Announcement of change of Chief Scientific Officer

2025.May.12

OBI announces OBI-833 termination and refocuses resources on ADC development

2025.May.06

Announcement on behalf of Amaran of not Distributing Dividends of 2024

2025.May.06

Announcement on behalf of Amaran that the BOD resolved to convene the 2025 Annual General Shareholders' Meeting

2025.May.01

OBI-902 TROP2 ADC has been granted by US FDA to proceed to Phase I/II human clinical trial

2025.Apr.30

Announcement for the expected date of the Board of Directors Meeting for 2025Q1 consolidated financial report is 2025/05/12

News

Latest News

Events

Latest events